CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback